Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020

Roche | Roche on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020 is hosted by Roche.

This session is available on demand.

Registration or viewing is completed on Roche's website. UPCOMING sends visitors using referral parameters.

This is an on-demand session that can be watched online.

The event covers SaaS.